In an effort to continue the successful launch of the s5i integrated IVUS system in the US and Europe, Volcano has ...
Siemens introduced the AXIOM Sensis XP - a new generation of integrated recording solutions that increases procedural efficiency, allowing for optimal patient care in the cath lab.
Siemens Medical Solutions previewed a hand-held ultrasound unit, the Acuson P10, intended primarily for triage and screening applications in acute care settings. In the future, personal imaging tools such as this could improve the standard of care for inpatient monitoring, critical care, outpatient specialty visits and bedside exams.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
ScImage announced that it is delivering a fully customizable reporting and workflow documentation solution for vascular procedures. The reporting solution will be offered as an add-on to the company’s award winning Enterprise PACS solution, PicomEnterprise.
The results of Boston Scientific's pivotal SPIRIT III clinical trial reaffirmed prior safety and efficacy data for the market-leading TAXUS Express2 Paclitaxel-Eluting Coronary Stent System and provided early positive data for the XIENCE V (PROMUS) Everolimus-Eluting Coronary Stent System.
As the pioneer of metabolic assessment and behavioral therapy technologies, BodyMedia is developing tools that empower health professionals to better treat patients with chronic health conditions such as obesity, diabetes and cardiovascular disease (CVD).
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Data released from the bridge-to-transplantation (BTT) arm of the HeartMate II Pivotal trial demonstrate that the device provides effective mechanical circulatory support as a bridge to transplantation for heart failure patients, and that these patients experience a lower number of adverse events and an improved quality of life while being supported by the device.
GE Healthcare announced the availability of the latest version of Centricity Cardiology CA1000 version 2.0, which provides unique tools for analysis, segmentation, measurements, annotation, filming and exporting of clinically relevant images.
The Virtual Explorer 3D Workstation is designed to analyze magnetic resonance (MR) images of the heart. It is a complete 3D, post-processing tool for MR analysis and display. The physician-friendly design offers a full range of features that will enhance MR imaging capability and functionality.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Vital Images Inc. featured its next generation of ViTALCardia, which includes a new EP planning tool and CathView, a new angiographic orientation.
Cheetah Medical Inc., developers of the Cheetah NICOM system for non-invasive, real-time cardiac output monitoring, announced that an article entitled "Evaluation of a Noninvasive Continuous Cardiac Output Monitoring System Based on Thoracic Bioreactance" has been accepted for publication in the American Journal of Physiology, a leading journal in the field of cardiac physiology.
Siemens Medical Solutions’ Ultrasound Division introduced the High Performance Imaging release for their ACUSON Sequoia echocardiography platform. The release adds two new transducers to the system: the 9L4 Multi-D and the 17L5 HD. Multi-D array transducer technology provides uniform elevation focusing for improved contrast and spatial resolution.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
March 28, 2007 - With an estimated 70 million Americans currently living with cardiovascular disease, the demand for services in the catheterization ("cath") lab continues to escalate. In fact, an estimated 4.21 million patient cases were performed at 1,970 cardiac cath lab sites in 2006, representing a 9 percent increase from 3.85 million in 2002.
ZOLL Medical Corp. has received FDA clearance to market and sell the ZOLL M Series with Real CPR Help technology. The device enables rescuers to instantly see and hear how well they are performing the rate and depth of CPR chest compressions. The M Series is the Company’s best-selling product to date. The approval extends Real CPR Help to ZOLL’s complete defibrillator product line.
Boston Scientific Corp. announced two-year results from the TAXUS V In-Stent Restenosis (ISR) trial, demonstrating that the TAXUS Express2 paclitaxel-eluting coronary stent system met its primary endpoint in the treatment of in-stent restenosis - the regrowth of diseased tissue into a previously stented artery utilizing bare-metal stents - compared to vascular brachytherapy.